Company intelligence / Profile preview

Idiag

Zürich, Zurich, Switzerlandidiag.ch ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Idiag AG is an active Swiss medical device and biotechnology company specializing in the development and commercialization of innovative diagnostic and therapeutic devices. The company operates primarily within the healthcare sector with a focus on medical technology. No clinical trial results are reported as their products are commercialized devices rather than investigational drugs.

Modalities: Device (medical devices for health monitoring and diagnostics)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Idiag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idiag.

Explore the full profile